Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study

Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study

Abstract Background Neoadjuvant chemoradiotherapy followed by surgery is recommended as the standard of care for locally advanced rectal cancer, reducing local recurrence but not distant metastasis. Intensified systemic therapy is warranted to reduce the risk of distant metastasis. The present study...

Full description

Bibliographic Details
Main Authors: Xin Yu, Qiao-xuan Wang, Wei-wei Xiao, Hui Chang, Zhi-fan Zeng, Zhen-hai Lu, Xiao-jun Wu, Gong Chen, Zhi-zhong Pan, De-sen Wan, Pei-rong Ding, Yuan-hong Gao
Format: Article
Language:English
Published: Wiley 2018-05-01
Series:Cancer Communications
Subjects:
Bevacizumab
Neoadjuvant chemoradiotherapy
Locally advanced rectal cancer
Safety
Efficacy
Online Access:http://link.springer.com/article/10.1186/s40880-018-0294-z

Internet

http://link.springer.com/article/10.1186/s40880-018-0294-z

Similar Items